Sandoz Inc – Company Profile and SWOT Analysis

Sandoz Inc – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Sandoz Inc (Sandoz), a division of Novartis AG, is a generic pharmaceutical company which develops, manufactures and distributes and sells a range of prescription medicines and protein and biosimilars worldwide. The company also provides intermediary products including active pharmaceutical ingredients (APIs), and biotechnology manufacturing services to other companies. It provides active ingredients and finished dosage forms of pharmaceuticals in the areas of dermatology, cancer, cardiovascular, respiratory, metabolism, central nervous system, pain, ophthalmic, gastrointestinal, and hormonal therapies. Sandoz distributes products to wholesalers, pharmacies, hospitals, and other healthcare outlets. Sandoz is headquartered in Princeton, New Jersey, the US.

Scope

• Detailed information on Sandoz Inc required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Sandoz Inc in the form of a SWOT analysis

• An in-depth view of the business model of Sandoz Inc including a breakdown and examination of key business segments

• News about Sandoz Inc, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Sandoz Inc and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Sandoz Inc as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Sandoz Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Bayer HealthCare Pharmaceuticals

Teva Pharmaceuticals USA Inc

Viatris Inc

Apotex Inc

Allergan Finance LLC

Hospira Inc

Dr. Reddy's Laboratories Inc

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Sandoz Inc - Key Facts

Sandoz Inc - Key Employees

Sandoz Inc - Major Products and Services

Sandoz Inc - History

Sandoz Inc - Company Statement

Sandoz Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Sandoz Inc - Business Description

Business Segment: Anti-Infectives

Overview

Performance

Business Segment: Biopharmaceuticals

Overview

Performance

Business Segment: Retail Generics

Overview

Performance

Geographical Segment: Asia/Africa/Australasia

Performance

Geographical Segment: Canada and Latin America

Performance

Geographical Segment: Europe

Performance

Geographical Segment: The US

Performance

Sandoz Inc - SWOT Analysis

SWOT Analysis - Overview

Sandoz Inc - Strengths

Sandoz Inc - Weaknesses

Sandoz Inc - Opportunities

Sandoz Inc - Threats

Sandoz Inc - Key Competitors

Section 3 – Company’s Lifesciences Financial Deals and Alliances

Sandoz Inc, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022

Sandoz Inc, Pharmaceuticals & Healthcare, Deals By Type, 2016 to YTD 2022

Sandoz Inc, Recent Deals Summary

Section 4 – Company’s Recent Developments

Aug 26, 2022: Novartis announces plans to spin-off Sandoz business

May 31, 2022: Sandoz announces new global ‘Act4Biosimilars’ initiative, to improve patient access and increase adoption by at least 30% in 30+ countries by 2030

Apr 06, 2022: Sandoz extends collaboration agreement to drive cutting-edge digital solutions in global fight against antimicrobial resistance (AMR)

Oct 04, 2021: Sandoz agrees to pay $185m to resolve US probe on generic drugs

Oct 01, 2021: Pharmaceutical companies pay over $400 million to resolve alleged false claims act liability for price-fixing of generic drugs

May 19, 2021: Sandoz plans $183m boost to antibiotics production in Europe

May 14, 2021: Courts approve settlement of Canadian ACTOS / Pioglitazone litigation

Section 5 – Appendix

Methodology

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Sandoz Inc, Key Facts

Sandoz Inc, Key Employees

Sandoz Inc, Major Products and Services

Sandoz Inc, History

Sandoz Inc, Other Locations

Sandoz Inc, Subsidiaries

Sandoz Inc, Key Competitors

Sandoz Inc, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022

Sandoz Inc, Pharmaceuticals & Healthcare, Deals By Type, 2016 to YTD 2022

Sandoz Inc, Recent Deals Summary

List of Figures

List of Figures

Sandoz Inc, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022

Sandoz Inc, Pharmaceuticals & Healthcare, Deals by Type, 2016 to YTD 2022

    Pricing

Quick Buy
Add to basket Enquire before buying

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports